Search

Contributor:

Arshad Khanani, MD

ARVO 2021 Coverage: TENAYA/LUCERNE Results—and Is Fluid OK in Wet AMD?

The Art of Drug Choice: Wet AMD and the Latest Data [Miniseries]

The Art of Drug Choice: International Panel in Wet AMD: Safety Data

The Art of Drug Choice: International Panel in Wet AMD: When and Why Switching Therapy Makes Sense

The Art of Drug Choice: International Panel in Wet AMD: The Pipeline

AAO Late Breaker: KSI-301 in DME Therapy

The Art of Drug Choice: International Panel in Wet AMD: Phase 3 and Real-World Data to Watch

OPTIC Study Data

OPTIC Study Data

Arshad M. Khanani, MD

Combined Surgery for Diabetic TRDs

Combined Surgery for Diabetic TRDs

Arshad Khanani, MD

RGX-314: Phase 1/2a Data

RGX-314: Phase 1/2a Data

Arshad Khanani, MD

Takeaways From New STAIRWAY Study Data

Takeaways From New STAIRWAY Study Data

Arshad Khanani, MD

Ranibizumab PDS: How LADDER Informed ARCHWAY

Ranibizumab PDS: How LADDER Informed ARCHWAY

Arshad Khanani, MD

AKB-9778 for the Treatment of Patients With Diabetic Eye Disease

AKB-9778 for the Treatment of Patients With Diabetic Eye Disease

Arshad Khanani, MD

Evaluation of Intraocular Inflammation and Pain Post Intravitreal Injection of Ranibizumab or Aflibercept: The PLANET Study

Evaluation of Intraocular Inflammation and Pain Post Intravitreal Injection of Ranibizumab or Aflibercept: The PLANET Study

Arshad M. Khanani, MD, Nikolas J.S. London, MD

GATHER2 Data at 1 and 2 Years

GATHER2 Data at 1 and 2 Years

Ramin Tadayoni, MD, PhD and Arshad Khanani, MD, MA

TRUCKEE Study Data

TRUCKEE Study Data

Ramin Tadayoni, MD, PhD and Arshad Khanani, MD, MA

A Look at Fluid in Wet AMD Patients With the Port Delivery System

A Look at Fluid in Wet AMD Patients With the Port Delivery System

Arshad Khanani, MD

Plasma Kallikrein Inhibition: A Novel Approach to DME

Plasma Kallikrein Inhibition: A Novel Approach to DME

Arshad Khanani, MD, MA, FASRS

Increasing Treatment Intervals in Wet AMD

Increasing Treatment Intervals in Wet AMD

Arshad M. Khanani, MD